Generic Name and Formulations:
Praziquantel 600mg; scored tabs.
Indications for BILTRICIDE:
For the treatment of infections due to: all species of schistosoma, and infections due to the liver flukes, Clonorchis sinensis/Opisthorchis viverrini.
Adults and Children:
Swallow whole with water during meals. <4yrs: not established. ≥4yrs: Schistosomiasis: 20mg/kg 3 times daily as a one day treatment, at intervals ≥4hrs and ≤6hrs. Clonorchiasis, opisthorchiasis: 25mg/kg 3 times daily as a one day treatment, at intervals ≥4hrs and ≤6hrs.
Ocular cysticercosis. Concomitant strong CYP450 inducers (eg, rifampin).
Renal or moderate-to-severe hepatic impairment. History of epilepsy. Cerebral cysticercosis: hospitalize patient for duration of treatment. Monitor patients with cardiac irregularities. Possible clinical deterioration (paradoxical reactions, serum sickness Jarisch-Herxheimer like reactions). Elderly. Pregnancy (Cat.B). Nursing mothers: not recommended and during subsequent 72hrs.
See Contraindications. Discontinue rifampin 4 weeks before giving praziquantel; may be restarted one day after completing praziquantel treatment. Potentiated by CYP450 inhibitors (eg, cimetidine, ketoconazole, itraconazole, erythromycin), grapefruit juice. Antagonized by CYP450 inducers (eg, phenytoin, phenobarbital, carbamazepine, dexamethasone).
Malaise, headache, dizziness, abdominal discomfort with or w/o nausea, fever, urticaria.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|